Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6
'Chem sex' commonly reported by UK gay men diagnosed with shigella
BMS combination cures 90% of genotype 1b hepatitis C in 24 weeks
Sofosbuvir + ribavirin is safe and effective for people with hepatitis C who have advanced liver disease
Abolishing HIV in Rwanda
Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B
AbbVie 3-drug combination cures 92 to 96% of hepatitis C patients with cirrhosis
AbbVie 2-drug combination + ribavirin achieves 100% cure in previously untreated genotype 4 hepatitis C
Sofosbuvir/ledipasvir co-formulation cures more than 90% of treatment-naive and retreated genotype 1 patients
